Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Bardejov

68 clinical trials in Bardejov, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Bardejov at a glance
68
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

68 trials in Bardejov

Open in trial search
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST GDNF FAMILY RECEPTOR ALPHA-LIKE
  • Sponsor:Ngm Biopharmaceuticals Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:SELTOREXANT
  • Sponsor:Janssen Cilag International
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:SlovakiaSlovakia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · Healthy volunteers
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Bardejov

What the registry says about research in the country

01 Cardiovascular Research

Research focusing on cardiovascular diseases and treatments, including studies on hypertriglyceridemia and stroke prevention. Multiple trials are investigating innovative therapies for atherosclerotic cardiovascular disease and heart failure.

  • Lipid management therapies
  • Stroke prevention in atrial fibrillation
  • Heart failure treatments

Novel approaches include testing medications like pelacarsen and obicetrapib for cardiovascular event reduction.

02 Respiratory Medicine

Comprehensive studies addressing respiratory conditions, with particular focus on asthma and COPD management. Research includes evaluation of new inhaler formulations and treatments.

  • Asthma control therapies
  • COPD treatments
  • RSV infection management

Trials are evaluating both established and innovative treatment combinations for optimal patient outcomes.

03 Neurological Disorders

Investigation of treatments for various neurological conditions, including epilepsy and depression. Studies focus on both pediatric and adult populations.

  • Epilepsy management
  • Depression treatment
  • Migraine prevention

Current research includes evaluating cenobamate for seizure control and new approaches for major depressive disorder.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).